Page last updated: 2024-10-22

albuterol and Fetal Distress

albuterol has been researched along with Fetal Distress in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Fetal Distress: A nonreassuring fetal status (NRFS) indicating that the FETUS is compromised (American College of Obstetricians and Gynecologists 1988). It can be identified by sub-optimal values in FETAL HEART RATE; oxygenation of FETAL BLOOD; and other parameters.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pincus, R1

Trials

1 trial available for albuterol and Fetal Distress

ArticleYear
Salbutamol infusion for premature labour--the Australian trials experience.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1981, Volume: 21, Issue:1

    Topics: Albuterol; Australia; Clinical Trials as Topic; Female; Fetal Distress; Fetus; Humans; Obstetric Lab

1981